Nu-Med Plus (NUMD) Current Leases (2019)
Nu-Med Plus (NUMD) posted Current Leases of $5039.0 for Q1 2019.
Nu-Med Plus (NUMD) Current Leases (2019) Analysis & Trends
Nu-Med Plus has reported Current Leases for 1 years, with the latest figure at $5039.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 5,039.00 |